Polarean Imaging (POLX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 1.28p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.88
  • 52 Week Low: 0.93
  • Currency: UK Pounds
  • Shares Issued: 1,207.03m
  • Volume: 202,205
  • Market Cap: £15.39m
  • Beta: 0.01

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
10-May-21 Stifel Buy 98.60p - - Reiteration
27-Jul-18 Northland Capital Partners Corporate 16.13p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

POLX Market Data

Currency UK Pounds
Share Price 1.28p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.88
52 Week Low 0.93
Volume 202,205
Shares Issued 1,207.03m
Market Cap £15.39m
Beta 0.01

POLX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
15.15% above the sector average15.15% above the sector average15.15% above the sector average15.15% above the sector average15.15% above the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

POLX Dividends

No dividends found

Trades for 14-Jul-2025

Time Volume / Share Price
11:04 769 @ 1.30p
11:04 6,301 @ 1.30p
09:56 8,180 @ 1.27p
09:27 8,180 @ 1.27p
08:41 75,000 @ 1.30p

POLX Key Personnel

CFO Charles Osborne
CEO Christopher von Jako

Top of Page